I spoke with one of their clinicians during my research phase
(PubMed) Harrison J, Rentz DM, McLaughlin T, et al
The lipid messenger OEA links dietary fat intake to satiety
said, The incidence of thyroid cancer in semaglutide-treated patients was less than 1%, suggesting no significant risk. More specifically, both semaglutide and tirzepatide are contraindicated for patients with a personal or family history of medullary thyroid cancer (MTC) or multiple endocrine neoplasia type-2 (MEN2)
Appetite and Satiety: The GLP-1 hormone targets specific areas in the brain that regulate appetite and food intake
You should contact your GP or diabetes care team if you experience: Persistent or worsening urine odour that does not improve with increased fluid intake or dietary modification Cloudy, dark, or blood-tinged urine , which may indicate infection, dehydration, or other urinary tract pathology Pain or burning sensation during urination , suggesting a possible urinary tract infection Increased urinary frequency or urgency , particularly if accompanied by discomfort Fever, chills, or lower back pain , which could signal a kidney infection requiring urgent treatment Symptoms of diabetic ketoacidosis , including a fruity breath odour, excessive thirst, confusion, rapid breathing, or persistent nausea and vomiting